Literature DB >> 2741915

Agranulocytosis associated with "Mexican aspirin" (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors.

J B Hargis1, V F La Russa, J Redmond, S W Kessler, D G Wright.   

Abstract

A case of acute, transient agranulocytosis and thrombocytopenia associated with ingestion of dipyrone is reported. This once widely used analgesic, which is now banned in the United States, was obtained by the patient as "aspirin" while traveling in Mexico. Studies of the effects of this patient's serum on purified CD34+ marrow cells, which were highly enriched for hematopoietic progenitors, showed not only a drug-dependent suppression of the in vitro growth of myeloid progenitors, as has been reported previously, but also a drug-dependent suppression of primitive multipotential progenitors (CFU-Mix) and erythroid progenitors (BFU-E). These findings indicate that autoimmune, antibody-hapten interactions which have been reported to occur in dipyrone- and aminopyrine-induced agranulocytosis are not restricted to the neutrophil lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741915     DOI: 10.1002/ajh.2830310314

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Use of Neo-melubrina, a banned antipyretic drug, in San Diego, California: a survey of patients and providers.

Authors:  L Taylor; S Abarca; B Henry; L Friedman
Journal:  West J Med       Date:  2001-09

2.  IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis.

Authors:  Sevket Arslan; Ramazan Ucar; Ahmet Zafer Caliskaner
Journal:  Eurasian J Med       Date:  2016-06

3.  Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.

Authors:  Matthias Huber; Frank Andersohn; Giselle Sarganas; Elisabeth Bronder; Andreas Klimpel; Michael Thomae; Christine Konzen; Reinhold Kreutz; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2014-11-08       Impact factor: 2.953

4.  Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.

Authors:  Thomas Stammschulte; Wolf-Dieter Ludwig; Bernd Mühlbauer; Elisabeth Bronder; Ursula Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  2015-07-15       Impact factor: 2.953

5.  Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response.

Authors:  Valerio Gozzoli; Miriam M Treggiari; Gian-Reto Kleger; Pascale Roux-Lombard; Marc Fathi; Claude Pichard; Jacques-André Romand
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 6.  Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.

Authors:  R E Parchment
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

7.  The using of a piglets as a model for evaluating the dipyrone hematological effects.

Authors:  Artur Burmańczuk; Andrzej Milczak; Tomasz Grabowski; Monika Osypiuk; Cezary Kowalski
Journal:  BMC Vet Res       Date:  2016-11-25       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.